Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding
Authors:
Open Access
- 1 September 2003
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 80 (3) , 564-570
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Peptide Substrate Specificities and Protein Cleavage Sites of Human Endometase/Matrilysin-2/Matrix Metalloproteinase-26Journal of Biological Chemistry, 2002
- Complex roles of tissue inhibitors of metalloproteinases in cancerOncogene, 2002
- Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targetsInternational Journal of Cancer, 2002
- The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasisTrends in Cell Biology, 2001
- Co-localization of matrix metalloproteinase-1 and mast cell tryptase in the human uterusMolecular Human Reproduction, 2001
- Identification and Characterization of Human Endometase (Matrix Metalloproteinase-26) from Endometrial TumorJournal of Biological Chemistry, 2000
- Matrix metalloproteinases in angiogenesis: a moving target for therapeutic interventionJournal of Clinical Investigation, 1999
- Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones.Journal of Clinical Investigation, 1994
- Vaginal bleeding patterns in women using once-a-month injectable contraceptivesContraception, 1994
- The Significance of Bleeding Patterns in Norplant Implant UsersObstetrics & Gynecology, 1991